210 related articles for article (PubMed ID: 11146726)
21. Ocular manifestations of HIV infection.
Jabs DA
Trans Am Ophthalmol Soc; 1995; 93():623-83. PubMed ID: 8719695
[TBL] [Abstract][Full Text] [Related]
22. Involvement of apoptosis and interferon-gamma in murine toxoplasmosis.
Shen DF; Matteson DM; Tuaillon N; Suedekum BK; Buggage RR; Chan CC
Invest Ophthalmol Vis Sci; 2001 Aug; 42(9):2031-6. PubMed ID: 11481268
[TBL] [Abstract][Full Text] [Related]
23. Immunological Molecular Responses of Human Retinal Pigment Epithelial Cells to Infection With
Lie S; Rochet E; Segerdell E; Ma Y; Ashander LM; Shadforth AMA; Blenkinsop TA; Michael MZ; Appukuttan B; Wilmot B; Smith JR
Front Immunol; 2019; 10():708. PubMed ID: 31118929
[TBL] [Abstract][Full Text] [Related]
24. Cytokine Signatures Associated With Early Onset, Active Lesions and Late Cicatricial Events of Retinochoroidal Commitment in Infants With Congenital Toxoplasmosis.
Carneiro AC; Machado AS; Béla SR; Costa JG; Andrade GM; Vasconcelos-Santos DV; Januário JN; Coelho-Dos-Reis JG; Ferro EA; Teixeira-Carvalho A; Vitor RW; Martins-Filho OA;
J Infect Dis; 2016 Jun; 213(12):1962-70. PubMed ID: 26946460
[TBL] [Abstract][Full Text] [Related]
25. Characterization of Toxoplasma gondii-specific T cells recovered from vitreous fluid of patients with ocular toxoplasmosis.
Feron EJ; Klaren VN; Wierenga EA; Verjans GM; Kijlstra A
Invest Ophthalmol Vis Sci; 2001 Dec; 42(13):3228-32. PubMed ID: 11726627
[TBL] [Abstract][Full Text] [Related]
26. The involvement of anti-inflammatory protein, annexin A1, in ocular toxoplasmosis.
Mimura KK; Tedesco RC; Calabrese KS; Gil CD; Oliani SM
Mol Vis; 2012; 18():1583-93. PubMed ID: 22740770
[TBL] [Abstract][Full Text] [Related]
27. Ocular toxoplasmosis in AIDS patients.
Gagliuso DJ; Teich SA; Friedman AH; Orellana J
Trans Am Ophthalmol Soc; 1990; 88():63-86; discussion 86-8. PubMed ID: 2095034
[TBL] [Abstract][Full Text] [Related]
28. Review for disease of the year: differential diagnosis of ocular toxoplasmosis.
Vasconcelos-Santos DV; Dodds EM; Oréfice F
Ocul Immunol Inflamm; 2011 Jun; 19(3):171-9. PubMed ID: 21595533
[TBL] [Abstract][Full Text] [Related]
29. [Toxoplasmosis and ocular pathology].
Schnyder CC
Schweiz Med Wochenschr Suppl; 1995; 65():82S-88S. PubMed ID: 7716457
[TBL] [Abstract][Full Text] [Related]
30. Toxoplasma gondii: P30 peptides recognition pattern in human toxoplasmosis.
Cardona N; de-la-Torre A; Siachoque H; Patarroyo MA; Gomez-Marin JE
Exp Parasitol; 2009 Oct; 123(2):199-202. PubMed ID: 19567250
[TBL] [Abstract][Full Text] [Related]
31. The national neonatal screening programme for congenital toxoplasmosis in Denmark: results from the initial four years, 1999-2002.
Schmidt DR; Hogh B; Andersen O; Fuchs J; Fledelius H; Petersen E
Arch Dis Child; 2006 Aug; 91(8):661-5. PubMed ID: 16861484
[TBL] [Abstract][Full Text] [Related]
32. Macrophages and dendritic cells in IRBP-induced experimental autoimmune uveoretinitis in B10RIII mice.
Jiang HR; Lumsden L; Forrester JV
Invest Ophthalmol Vis Sci; 1999 Dec; 40(13):3177-85. PubMed ID: 10586940
[TBL] [Abstract][Full Text] [Related]
33. Congenital toxoplasmic retinochoroiditis in a mouse model.
Hay J; Lee WR; Dutton GN; Hutchison WM; Siim JC
Ann Trop Med Parasitol; 1984 Apr; 78(2):109-16. PubMed ID: 6742924
[TBL] [Abstract][Full Text] [Related]
34. [Congenital toxoplasmosis. Remarks apropos of serologic surveillance in 15,000 pregnant women].
Lapierre J; Tourte-Schaefer C; Heyer F; Nessmann C; Timbart MF; Beaujouan L
Sem Hop; 1983 Nov; 59(40):2741-5. PubMed ID: 6316531
[TBL] [Abstract][Full Text] [Related]
35. Ocular toxoplasmosis signs in mice embryo.
Tedesco RC; Vitor RW; Brandão GP; Calabrese KS
Micron; 2007; 38(7):729-33. PubMed ID: 17596951
[TBL] [Abstract][Full Text] [Related]
36. Effects of Congenital Ocular Toxoplasmosis on Peripheral Retinal Vascular Development in Premature Infants at Low Risk for Retinopathy of Prematurity.
Hasanreisoğlu M; Özdek Ş; Gülpınar İkiz GD; Aktaş Z; Atalay T
Turk J Ophthalmol; 2019 Sep; 49(4):230-234. PubMed ID: 31486615
[TBL] [Abstract][Full Text] [Related]
37. Congenital toxoplasmosis: long-term follow-up.
Koppe JG; Kloosterman GJ
Padiatr Padol; 1982; 17(2):171-9. PubMed ID: 7099676
[TBL] [Abstract][Full Text] [Related]
38. Outbreak of acquired ocular toxoplasmosis involving 248 patients.
Balasundaram MB; Andavar R; Palaniswamy M; Venkatapathy N
Arch Ophthalmol; 2010 Jan; 128(1):28-32. PubMed ID: 20065213
[TBL] [Abstract][Full Text] [Related]
39. Experimental ocular toxoplasmosis induced in naive and preinfected mice by intracameral inoculation.
Hu MS; Schwartzman JD; Lepage AC; Khan IA; Kasper LH
Ocul Immunol Inflamm; 1999 Mar; 7(1):17-26. PubMed ID: 10410871
[TBL] [Abstract][Full Text] [Related]
40. Ocular impairment of toxoplasmosis.
Antoniazzi E; Guagliano R; Meroni V; Pezzotta S; Bianchi PE
Parassitologia; 2008 Jun; 50(1-2):35-6. PubMed ID: 18693554
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
